# US Cycle Control and Blood Pressure Study

> **NCT00920985** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 346 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Gestodene/EE (FC Patch Low, BAY86-5016)
- **DRUG:** Oral contraceptive (equivalent to the active treatment tablets of Levlite), 21-day blister SH D00593A

## Key facts

- **NCT ID:** NCT00920985
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920985, "US Cycle Control and Blood Pressure Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00920985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*